Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Design and synthesis of COX-2 inhibitors related to indomethacin

Sep. 29, 1997

Tachykinin antagonists prepared at Pfizer

Sep. 29, 1997

Amgen seeks partner for inflammation R&D program

Sep. 23, 1997

Generic naproxen introduced in U.S.

Sep. 22, 1997

New NO donor-containing NSAID derivatives from NitroMed

Sep. 19, 1997

Fujisawa discloses new PDE IV/TNF inhibitors

Sep. 18, 1997

More on SE-205, a new MMP/TNF inhibitor from DuPont Merck

Sep. 16, 1997

Merck Frosst reports further data on COX-2 inhibitor L-768277

Sep. 16, 1997

Potent and selective COX-2 inhibitors synthesized at Boehringer Ingelheim

Sep. 16, 1997

PDL licenses antibody humanization patents to IDEC

Sep. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...